Chris Schelling
2021
In 2021, Chris Schelling earned a total compensation of $552.2K as President and Chief Executive Officer at Opexa Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
| Option Awards | $116,236 |
|---|---|
| Salary | $436,000 |
| Total | $552,236 |
Schelling received $436K in salary, accounting for 79% of the total pay in 2021.
Schelling also received $116.2K in option awards.
Rankings
In 2021, Chris Schelling's compensation ranked 10,506th out of 12,405 executives tracked by ExecPay. In other words, Schelling earned more than 15.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,506 out of 12,405 | 15th |
Division Manufacturing | 4,644 out of 5,494 | 16th |
Major group Chemicals And Allied Products | 2,087 out of 2,369 | 12th |
Industry group Drugs | 1,851 out of 2,090 | 11th |
Industry Pharmaceutical Preparations | 1,369 out of 1,537 | 11th |
Source: SEC filing on April 15, 2022.
Schelling's colleagues
We found two more compensation records of executives who worked with Chris Schelling at Opexa Therapeutics in 2021.
News
Opexa Therapeutics CEO Chris Schelling's 2022 pay jumps 51% to $834K
April 14, 2023
Opexa Therapeutics Chief Business Officer Jefferson Davis receives $635K in 2021
April 15, 2022
Opexa Therapeutics CEO Chris Schelling's 2020 pay falls 54% to $676K
April 16, 2021
Opexa Therapeutics CEO Chris Schelling's 2019 pay jumps 167% to $1.5M
October 14, 2020
Opexa Therapeutics CEO Chris Schelling's 2018 pay slips 6% to $550K
April 12, 2019